Clinical trial
Effect of Exenatide on 24h-UAER in Patients With Diabetic Nephropathy: a 24- Week Study
NCT02690883 is registered in ClinicalTrials.gov with Nanfang Hospital, Southern Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Exenatide on 24h-UAER in Patients With Diabetic Nephropathy: a 24- Week Study
- Lead sponsor
- Nanfang Hospital, Southern Medical University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 8, 2016
- Completion date
- December 30, 2019
- Enrollment
- 92 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.